Bellicum Pharmaceuticals is a biopharmaceutical company that develops immunotherapy drugs to treat hematological cancers and solid tumors. Its flagship products are BPX-601, an autologous GoCAR-T product candidate, and BPX-603, a dual-switch GoCAR-T product candidate. The company also has collaboration and license agreements with other pharmaceutical companies.